Xu Song MS AstraZeneca

Xu Song is currently a Senior Director in BioPharmaceuticals R&D in AstraZeneca. His work scope focuses on CMC activities in biologics product development as CMC lead, drug product technology transfer lead, as well as packaging development. Prior to AstraZeneca, Xu worked at Bristol Myers Squibb, Becton Dickinson, and Johnson & Johnson. Xu Song obtained a Master's degree in Plastic Engineering from University of Massachusetts Lowell USA and Bachelor's degree in Chemistry from Nankai University PR China.